生命科学资讯

Illumina’s China Setback Leaves A Discounted Genomics Leader - Finimize

Will Illumina Inc. stock outperform international peers - Trade Risk Report & Free Fast Entry Momentum Trade Alerts - moha.gov.vn

Is Illumina Inc. stock undervalued vs historical averages - Trend Reversal & Fast Moving Trade Plans - BỘ NỘI VỤ

When a worldwide community comes together - Illumina

Illumina price attacks important resistance - Forecast today - 26-11-2025 - Economies.com

Illumina Completes $500M Notes Offering for Expansion - TipRanks

How Will Analyst Reactions to ILMN’s Wolfe Conference Pitch Shape Confidence in Its Turnaround Plan? - simplywall.st

Illumina CEO Jacob Thaysen: Anchoring “In China, For China” to Drive a New Chapter in China’s Healthcare Through Technology - Caixin Global

Illumina (ILMN): A Fresh Look at Valuation as Protein Prep Gains Ground in Global Research Labs - simplywall.st

Illumina, Inc. Stock (ILMN) Opinions on Strategic Growth and Market Expansion - Quiver Quantitative

The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - MSN

3 Reasons to Sell ILMN and 1 Stock to Buy Instead - Finviz

Tackling antimicrobial resistance, one genome at a time - Illumina

Leadership Perspectives: Illumina leads the industry in genomic AI - Illumina

Is Illumina Inc. (ILU) stock a buy on weakness - Portfolio Performance Report & Accurate Buy Signal Alerts - newser.com

Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study - PR Newswire

Illumina To Webcast Upcoming Investor Conference - PR Newswire

Illumina (ILMN): Exploring Valuation Following Recent Share Price Rebound - Yahoo Finance

Illumina, Inc. (NASDAQ:ILMN) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected - simplywall.st

Illumina: An Excellent Profit Margin And The Sequencing Genome Market Will Unlock Value - Seeking Alpha